Genome-wide association study of Stevens-Johnson syndrome and Toxic Epidermal Necrolysis in Europe

Orphanet Journal of Rare Diseases

Volumn 6, Issue 1, 2011, Pages

  Génin, Emmanuelle ^a,b   Schumacher, Martin ^c   Roujeau, Jean Claude ^a,d   Naldi, Luigi ^e   Liss, Yvonne ^f   Kazma, Rémi ^a,b   Sekula, Peggy ^c   Hovnanian, Alain ^a,g,h   Mockenhaupt, Maja ^f  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c UNIVERSITY OF FREIBURG   (Germany)

^d HENRI MONDOR HOSPITAL   (France)

^e UNIVERSITY OF MILAN   (Italy)

^f Dokumentationszentrum Schwerer Hautreaktionen (DZh)   (Germany)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CARBAMAZEPINE; HLA B ANTIGEN; PHENYTOIN; DRUG; HLA B*58:01 ANTIGEN; HLA-B*58:01 ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; EUROPE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; SAMPLE; SINGLE NUCLEOTIDE POLYMORPHISM; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; CASE CONTROL STUDY; CAUCASIAN; GENE FREQUENCY; GENETICS; RISK;

ALLOPURINOL; CASE-CONTROL STUDIES; EPIDERMAL NECROLYSIS, TOXIC; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; HLA-B ANTIGENS; HUMANS; MALE; ODDS RATIO; PHARMACEUTICAL PREPARATIONS; STEVENS-JOHNSON SYNDROME;

EID: 79960882627     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-6-52     Document Type: Article

References (50)

1. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J Lazarou, BH Pomeranz, PN Corey, Jama 1998 279 15 1200 1205 10.1001/jama.279.15.1200 9555760 (Pubitemid 28193431)
2. Cutaneous drug reactions. CK Svensson, EW Cowen, AA Gaspari, Pharmacol Rev 2001 53 3 357 379 11546834 (Pubitemid 32852017)
3. Update on cutaneous drug reactions. SE Wolverton, Adv Dermatol 1997 13 65 84 9551141
4. Severe adverse cutaneous reactions to drugs. JC Roujeau, RS Stern, N Engl J Med 1994 331 19 1272 1285 10.1056/NEJM199411103311906 7794310 (Pubitemid 24333193)
5. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. A Auquier-Dunant, M Mockenhaupt, L Naldi, O Correia, W Schroder, JC Roujeau, Arch Dermatol 2002 138 8 1019 1024 10.1001/archderm.138.8.1019 12164739 (Pubitemid 34875605)
6. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. B Rzany, M Mockenhaupt, S Baur, W Schroder, U Stocker, J Mueller, N Hollander, R Bruppacher, E Schopf, J Clin Epidemiol 1996 49 7 769 773 10.1016/0895-4356(96)00035-2 8691227 (Pubitemid 26280728)
7. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. S Halevy, PD Ghislain, M Mockenhaupt, JP Fagot, JN Bavinck Bouwes, A Sidoroff, L Naldi, A Dunant, C Viboud, JC Roujeau, J Am Acad Dermatol 2008 58 1 25 32 10.1016/j.jaad.2007.08. 036 17919772 (Pubitemid 350298142)
8. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. M Mockenhaupt, C Viboud, A Dunant, L Naldi, S Halevy, JN Bavinck Bouwes, A Sidoroff, J Schneck, JC Roujeau, A Flahault, J Invest Dermatol 2008 128 1 35 44 10.1038/sj.jid.5701033 17805350 (Pubitemid 350249390)
9. Genetic susceptibility to adverse drug reactions. M Pirmohamed, BK Park, Trends Pharmacol Sci 2001 22 6 298 305 10.1016/S0165-6147(00)01717-X 11395158 (Pubitemid 32523913)
10. Familial hypersensitivity to allopurinol with subsequent desensitization. RD Melsom, Rheumatology (Oxford) 1999 38 12 1301 10.1093/rheumatology/38.12. 1301
11. Familial occurrence of fixed drug eruptions. R Pellicano, A Silvestris, M Iannantuono, G Ciavarella, M Lomuto, Acta Derm Venereol 1992 72 4 292 293 1357892
12. Genetic susceptibility to toxic epidermal necrolysis. JC Roujeau, TN Huynh, C Bracq, JC Guillaume, J Revuz, R Touraine, Arch Dermatol 1987 123 9 1171 1173 10.1001/archderm.123.9.1171 3477129 (Pubitemid 17119310)
13. HLA phenotypes and bullous cutaneous reactions to drugs. JC Roujeau, C Bracq, NT Huyn, E Chaussalet, C Raffin, N Duedari, Tissue Antigens 1986 28 4 251 254 3544335 (Pubitemid 17201461)
14. Medical genetics: a marker for Stevens-Johnson syndrome. WH Chung, SI Hung, HS Hong, MS Hsih, LC Yang, HC Ho, JY Wu, YT Chen, Nature 2004 428 6982 486 10.1038/428486a 15057820 (Pubitemid 38480527)
15. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. SI Hung, WH Chung, LB Liou, CC Chu, M Lin, HP Huang, YL Lin, JL Lan, LC Yang, HS Hong, MJ Chen, PC Lai, MS Wu, CY Chu, KH Wang, CH Chen, CS Fann, JY Wu, YT Chen, Proc Natl Acad Sci USA 2005 102 11 4134 4139 10.1073/pnas.0409500102 15743917 (Pubitemid 40388568)
16. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. C Lonjou, N Borot, P Sekula, N Ledger, L Thomas, S Halevy, L Naldi, JN Bouwes-Bavinck, A Sidoroff, C de Toma, M Schumacher, JC Roujeau, A Hovnanian, M Mockenhaupt, RegiSCAR study group, Pharmacogenetics and genomics 2008 18 2 99 107 10.1097/FPC.0b013e3282f3ef9c 18192896
17. A marker for Stevens-Johnson syndrome.: ethnicity matters. C Lonjou, L Thomas, N Borot, N Ledger, C de Toma, H LeLouet, E Graf, M Schumacher, A Hovnanian, M Mockenhaupt, JC Roujeau, RegiSCAR Group, Pharmacogenomics J 2006 6 4 265 268 16415921 (Pubitemid 44137953)
18. Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. M Pirmohamed, JB Arbuckle, CE Bowman, M Brunner, DK Burns, O Delrieu, LP Dix, JA Twomey, RS Stern, Pharmacogenomics 2007 8 12 1661 1691 10.2217/14622416.8.12.1661 18085998
19. Of race, ethnicity, and rash: the genetics of antiepileptic drug-induced skin reactions. JW Miller, Epilepsy Curr 2008 8 5 120 121 18852831
20. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases. R Abe, J Dermatol Sci 2008 52 3 151 159 10.1016/j.jdermsci.2008.06.003 18657400
21. Genetic factors in the predisposition to drug-induced hypersensitivity reactions. M Pirmohamed, Aaps J 2006 8 1 20 26 10.1208/aapsj080103 16584129 (Pubitemid 44603868)
22. Investigation of the fine structure of European populations with applications to disease association studies. SC Heath, IG Gut, P Brennan, JD McKay, V Bencko, E Fabianova, L Foretova, M Georges, V Janout, M Kabesch, et al. Eur J Hum Genet 2008 16 12 1413 1429 10.1038/ejhg.2008.210 19020537
23. PLINK: a tool set for whole-genome association and population-based linkage analyses. S Purcell, B Neale, K Todd-Brown, L Thomas, MA Ferreira, D Bender, J Maller, P Sklar, PI de Bakker, MJ Daly, PC Sham, American journal of human genetics 2007 81 3 559 575 10.1086/519795 17701901 (Pubitemid 47330214)
24. Principal components analysis corrects for stratification in genome-wide association studies. AL Price, NJ Patterson, RM Plenge, ME Weinblatt, NA Shadick, D Reich, Nature genetics 2006 38 8 904 909 10.1038/ng1847 16862161 (Pubitemid 44141658)
25. Population structure and eigenanalysis. N Patterson, AL Price, D Reich, PLoS genetics 2006 2 12 190 10.1371/journal.pgen.0020190 17194218 (Pubitemid 46045188)
26. Genomic control for association studies. B Devlin, K Roeder, Biometrics 1999 55 4 997 1004 10.1111/j.0006-341X.1999.00997.x 11315092
27. Stata Statistical Software: Release 10. StataCorp, College Station, TX StataCorp LP 2007
28. Genetic association and gene-environment interaction: a new method for overcoming the lack of exposure information in controls. R Kazma, MC Babron, E Genin, Am J Epidemiol 173 2 225 235
29. A HapMap harvest of insights into the genetics of common disease. TA Manolio, LD Brooks, FS Collins, J Clin Invest 2008 118 5 1590 1605 10.1172/JCI34772 18451988 (Pubitemid 351632361)
30. On the allelic spectrum of human disease. DE Reich, ES Lander, Trends Genet 2001 17 9 502 510 10.1016/S0168-9525(01)02410-6 11525833 (Pubitemid 32763048)
31. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. KE Lohmueller, CL Pearce, M Pike, ES Lander, JN Hirschhorn, Nature genetics 2003 33 2 177 182 10.1038/ng1071 12524541 (Pubitemid 36177070)
32. Common and rare variants in multifactorial susceptibility to common diseases. W Bodmer, C Bonilla, Nature genetics 2008 40 6 695 701 10.1038/ng.f.136 18509313 (Pubitemid 351748875)
33. Finding the missing heritability of complex diseases. TA Manolio, FS Collins, NJ Cox, DB Goldstein, LA Hindorff, DJ Hunter, MI McCarthy, EM Ramos, LR Cardon, A Chakravarti, JH Cho, AE Guttmacher, A Kong, L Kruglyak, E Mardis, CN Rotimi, M Slatkin, D Valle, AS Whittemore, M Boehnke, AG Clark, EE Eichler, G Gibson, JL Haines, TF Mackay, SA McCarroll, PM Visscher, Nature 2009 461 7265 747 753 10.1038/nature08494 19812666
34. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. IP Gorlov, OY Gorlova, SR Sunyaev, MR Spitz, CI Amos, American journal of human genetics 2008 82 1 100 112 10.1016/j.ajhg.2007.09.006 18179889 (Pubitemid 351726083)
35. Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery. MI McCarthy, Genome medicine 2009 1 7 66 10.1186/gm66 19591663
36. Rare variant hypothesis for multifactorial inheritance: susceptibility to colorectal adenomas as a model. NS Fearnhead, B Winney, WF Bodmer, Cell cycle (Georgetown, Tex 2005 4 4 521 525 10.4161/cc.4.4.1591 (Pubitemid 41359770)
37. Assessing the evolutionary impact of amino acid mutations in the human genome. AR Boyko, SH Williamson, AR Indap, JD Degenhardt, RD Hernandez, KE Lohmueller, MD Adams, S Schmidt, JJ Sninsky, SR Sunyaev, TJ White, R Nielsen, AG Clark, CD Bustamante, PLoS genetics 2008 4 5 1000083 10.1371/journal.pgen. 1000083 18516229 (Pubitemid 351811492)
38. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. GV Kryukov, LA Pennacchio, SR Sunyaev, American journal of human genetics 2007 80 4 727 739 10.1086/513473 17357078 (Pubitemid 46564409)
39. Multiple advantageous amino acid variants in the NAT2 gene in human populations. F Luca, G Bubba, M Basile, R Brdicka, E Michalodimitrakis, O Rickards, G Vershubsky, L Quintana-Murci, AI Kozlov, A Novelletto, PloS one 2008 3 9 3136 10.1371/journal.pone.0003136 18773084
40. Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. E Patin, LB Barreiro, PC Sabeti, F Austerlitz, F Luca, A Sajantila, DM Behar, O Semino, A Sakuntabhai, N Guiso, B Gicquel, K McElreavey, RM Harding, E Heyer, L Quintana-Murci, American journal of human genetics 2006 78 3 423 436 10.1086/500614 16416399 (Pubitemid 43291225)
41. Population genetic structure of variable drug response. JF Wilson, ME Weale, AC Smith, F Gratrix, B Fletcher, MG Thomas, N Bradman, DB Goldstein, Nature genetics 2001 29 3 265 269 10.1038/ng761 11685208 (Pubitemid 33096450)
42. A statistical method for predicting classical HLA alleles from SNP data. S Leslie, P Donnelly, G McVean, American journal of human genetics 2008 82 1 48 56 10.1016/j.ajhg.2007.09.001 18179884 (Pubitemid 351726079)
43. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. PI de Bakker, G McVean, PC Sabeti, MM Miretti, T Green, J Marchini, X Ke, AJ Monsuur, P Whittaker, M Delgado, J Morrison, A Richardson, EC Walsh, X Gao, L Galver, J Hart, DA Hafler, M Pericak-Vance, JA Todd, MJ Daly, J Trowsdale, C Wijmenga, TJ Vyse, S Beck, SS Murray, M Carrington, S Gregory, P Deloukas, JD Rioux, Nature genetics 2006 38 10 1166 1172 10.1038/ng1885 16998491 (Pubitemid 44470362)
44. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. GR Kazeem, C Cox, J Aponte, J Messenheimer, C Brazell, AC Nelsen, MR Nelson, E Foot, Pharmacogenetics and genomics 2009 19 9 661 665 10.1097/FPC.0b013e32832c347d 19668019
45. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. W Tassaneeyakul, T Jantararoungtong, P Chen, PY Lin, S Tiamkao, U Khunarkornsiri, P Chucherd, P Konyoung, S Vannaprasaht, C Choonhakarn, P Pisuttimarn, A Sangviroon, W Tassaneeyakul, Pharmacogenetics and genomics 2009 19 9 704 709 10.1097/FPC.0b013e328330a3b8 19696695
46. Optimizing the power of genome-wide association studies by using publicly available reference samples to expand the control group. JJ Zhuang, K Zondervan, F Nyberg, C Harbron, A Jawaid, LR Cardon, BJ Barratt, AP Morris, Genetic epidemiology 2010 Advance Online
47. Genotype-based matching to correct for population stratification in large-scale case-control genetic association studies. W Guan, L Liang, M Boehnke, GR Abecasis, Genetic epidemiology 2009 33 6 508 517 10.1002/gepi.20403 19170134
48. On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. D Luca, S Ringquist, L Klei, AB Lee, C Gieger, HE Wichmann, S Schreiber, M Krawczak, Y Lu, A Styche, B Devlin, K Roeder, M Trucco, American journal of human genetics 2008 82 2 453 463 10.1016/j.ajhg.2007.11.003 18252225
49. A human genome diversity cell line panel. HM Cann, C de Toma, L Cazes, MF Legrand, V Morel, L Piouffre, J Bodmer, WF Bodmer, B Bonne-Tamir, A Cambon-Thomsen, Z Chen, J Chu, C Carcassi, L Contu, R Du, L Excoffier, GB Ferrara, JS Friedlaender, H Groot, D Gurwitz, T Jenkins, RJ Herrera, X Huang, J Kidd, KK Kidd, A Langaney, AA Lin, SQ Mehdi, P Parham, A Piazza, MP Pistillo, Y Qian, Q Shu, J Xu, S Zhu, JL Weber, HT Greely, MW Feldman, G Thomas, J Dausset, LL Cavalli-Sforza, Science (New York, NY 2002 296 5566 261 262 (Pubitemid 34303653)
50. fdrtool: a versatile R package for estimating local and tail area-based false discovery rates. K Strimmer, Bioinformatics (Oxford, England) 2008 24 12 1461 1462 10.1093/bioinformatics/btn209 (Pubitemid 351851002)